Inventor
MARTIN SCOTT W
US25 patents
⚠️ This page may combine multiple inventors who share the name “MARTIN SCOTT W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
21 patentsUS7153848B2Dec 26, 2006
Inhibitors of HCV replication
BRISTOL MYERS SQUIBB CO90 citations98
US5869509AFeb 9, 1999
Diphenyl oxadiazolones as potassium channel modulators
BRISTOL MYERS SQUIBB CO63 citations96
US7348425B2Mar 25, 2008
Inhibitors of HCV replication
BRISTOL MYERS SQUIBB CO59 citations94
US7473688B2Jan 6, 2009
Indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO26 citations92
US6271249B1Aug 7, 2001
Diphenyl imidazoles as potassium channel modulators
BRISTOL MYERS SQUIBB CO38 citations92
US6077861AJun 20, 2000
Diphenyl triazoles as potassium channel modulators
BRISTOL MYERS SQUIBB CO30 citations92
US7183302B2Feb 27, 2007
Iminothiazolidinones as inhibitors of HCV replication
BRISTOL MYERS SQUIBB CO32 citations89
US9850225B2Dec 26, 2017
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO13 citations84
US7521441B2Apr 21, 2009
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO18 citations84
US7456165B2Nov 25, 2008
HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO17 citations84
US5254576AOct 19, 1993
Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
BRISTOL MYERS SQUIBB CO18 citations81
US7112601B2Sep 26, 2006
Cycloalkyl heterocycles for treating hepatitis C virus
BRISTOL MYERS SQUIBB CO15 citations80
US11866430B2Jan 9, 2024
Naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO3 citations73
US5380854AJan 10, 1995
Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
BRISTOL MYERS SQUIBB CO10 citations73
US10669272B2Jun 2, 2020
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO4 citations70
US7652004B2Jan 26, 2010
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO4 citations62
US6479482B2Nov 12, 2002
Alkylamine derivatives of dihydropyridine NPY antagonists
BRISTOL MYERS SQUIBB CO2 citations62
US11713316B2Aug 1, 2023
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US10954238B1Mar 23, 2021
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US7642251B2Jan 5, 2010
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO1 citations51
US11964973B2Apr 23, 2024
Substituted bicyclic compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations50